A study of the polymorphism and ethnic distribution differences of human serum paraoxonase
β Scribed by M. Geldmacher-V. Mallinckrodt; T. L. Diepgen; C. Duhme; G. Hommel
- Publisher
- John Wiley and Sons
- Year
- 1983
- Tongue
- English
- Weight
- 519 KB
- Volume
- 62
- Category
- Article
- ISSN
- 0002-9483
No coin nor oath required. For personal study only.
β¦ Synopsis
The enzyme serum paraoxonase shows a polymorphism in Europeans which is governed by two alleles. The first allele has a gene frequency plow of 0.716-0.777, and is manifested as a low activity group in homozygotes. More than 50% of all European test subjects can be included in this group. A second allele with a gene frequency ghi& of 0.223-0.284 was found in typical European distributions and is manifested in both the form of a second heterozygotic and a third homozygotic group with high activities. The Hardy-Weinberg rule for a two-allele model is valid for the distribution. The gene frequency plow of the first allele decreases as one moves from Europe in the direction of Africa and Asia. In typical Mongoloid and Negroid collectives, less than 10% of the population can be included in the low-activity group, a group which is not even demonstrable in the Aborigines of Australia. The serum paraoxonase of the Aborigine population shows unimodal distribution.
The validity of the Hardy-Weinberg rule for a three-allele model must be rejected in all examined collectives. Human serum paraoxonase shows neither age-related changes in activity nor sex-dependent activity differences.
π SIMILAR VOLUMES
The partition of zinc in human serum between two major zinc-binding proteins. albumin and cY,-macroglobulin, was studied in 28 control subjects and in 156 hospitkliied patients\_ Albumin-bound zinc was both the major and the more dynamic of the serum zinc components. Over a wide range of values the
## Abstract __Background__: Inhibition studies on PON1 as an organophosphateβhydrolyzing and atheroprotective enzyme could be useful in elucidating the function of PON1. This study is aimed at examining the in vitro effects of the flavonoid naringenin on PON1 activity in human serum and purified en